These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2428825)

  • 1. Progestin effect on cell proliferation and 17 beta-hydroxysteroid dehydrogenase activity in normal human breast cells in culture.
    Gompel A; Malet C; Spritzer P; Lalardrie JP; Kuttenn F; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1174-80. PubMed ID: 2428825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17 beta-Hydroxysteroid dehydrogenase activity in human breast epithelial cell and fibroblast cultures.
    Prud'homme JF; Malet C; Gompel A; Lalardrie JP; Ochoa C; Boue A; Mauvais-Jarvis P; Kuttenn F
    Endocrinology; 1984 May; 114(5):1483-9. PubMed ID: 6232126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of progestins, estrogens, and antihormones on growth and lactate dehydrogenase in the human breast cancer cell line T47D.
    Hissom JR; Bowden RT; Moore MR
    Endocrinology; 1989 Jul; 125(1):418-23. PubMed ID: 2737155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiestrogens and normal human breast cell proliferation].
    Mauvais-Jarvis P; Gompel A; Malet C; Kuttenn F
    Ann Endocrinol (Paris); 1989; 50(3):181-8. PubMed ID: 2683973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD; Greene GL; Katzenellenbogen BS
    Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture.
    Vignon F; Bardon S; Chalbos D; Rochefort H
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1124-30. PubMed ID: 6682424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RU486, a progestin and glucocorticoid antagonist, inhibits the growth of breast cancer cells via the progesterone receptor.
    Bardon S; Vignon F; Chalbos D; Rochefort H
    J Clin Endocrinol Metab; 1985 Apr; 60(4):692-7. PubMed ID: 3972969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference between R5020 and the antiprogestin RU486 in antiproliferative effects on human breast cancer cells.
    Gill PG; Vignon F; Bardon S; Derocq D; Rochefort H
    Breast Cancer Res Treat; 1987 Oct; 10(1):37-45. PubMed ID: 3689980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RU486, a progestin antagonist, binds to progesterone receptors in a human endometrial cancer cell line and reverses the growth inhibition by progestins.
    Terakawa N; Shimizu I; Tanizawa O; Matsumoto K
    J Steroid Biochem; 1988 Aug; 31(2):161-6. PubMed ID: 2457133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17 beta-estradiol dehydrogenase (E2DH) activity in T47D cells.
    Malet C; Vacca A; Kuttenn F; Mauvais-Jarvis P
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5A):769-75. PubMed ID: 1958511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estradiol 17 beta-hydroxysteroid dehydrogenase activity in human breast fibroadenomas.
    Fournier S; Kuttenn F; de Cicco F; Baudot N; Malet C; Mauvais-Jarvis P
    J Clin Endocrinol Metab; 1982 Sep; 55(3):428-33. PubMed ID: 6954155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
    Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor is required for progestin-induced epithelial cell proliferation and alveolar-like morphogenesis in serum-free culture of normal mammary epithelial cells.
    Sunil N; Bennett JM; Haslam SZ
    Endocrinology; 2002 Aug; 143(8):2953-60. PubMed ID: 12130561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth stimulation of T47D human breast cancer cells by the anti-progestin RU486.
    Bowden RT; Hissom JR; Moore MR
    Endocrinology; 1989 May; 124(5):2642-4. PubMed ID: 2707170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth inhibition and increase of insulin receptors in antiestrogen-resistant T47DCO human breast cancer cells by progestins: implications for endocrine therapies.
    Horwitz KB; Freidenberg GR
    Cancer Res; 1985 Jan; 45(1):167-73. PubMed ID: 3838085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of T47D human breast cancer cell growth by the synthetic progestin R5020: effects of serum, estradiol, insulin, and EGF.
    Gill PG; Tilley WD; De Young NJ; Lensink IL; Dixon PD; Horsfall DJ
    Breast Cancer Res Treat; 1991 Dec; 20(1):53-62. PubMed ID: 1813069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tamoxifen and hydroxytamoxifen isomers versus estradiol effects on normal human breast cells in culture.
    Malet C; Gompel A; Spritzer P; Bricout N; Yaneva H; Mowszowicz I; Kuttenn F; Mauvais-Jarvis P
    Cancer Res; 1988 Dec; 48(24 Pt 1):7193-9. PubMed ID: 3056610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiestrogen action of progesterone in breast tissue.
    Mauvais-Jarvis P; Kuttenn F; Gompel A
    Breast Cancer Res Treat; 1986; 8(3):179-88. PubMed ID: 3297211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal breast cells in culture. Effect of estrogens, progestins, and antiestrogens.
    Mauvais-Jarvis P; Kuttenn F; Malet C; Gompel A
    Ann N Y Acad Sci; 1990; 595():117-29. PubMed ID: 2375601
    [No Abstract]   [Full Text] [Related]  

  • 20. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
    Horwitz KB
    Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.